1. Introduction {#sec1}
===============

World health organization defines diarrhoea as the passage of three or more loose or liquid stools per day (or more frequent passage than is normal for the individual ([@bib189]). Worldwide, diarrhoeal diseases are reported as the leading cause of mortality among children aged five years and below ([@bib173]). In some parts of the world, they account for higher mortality rates than all other causes combined ([@bib133]; [@bib173]). Childhood diarrhoea affecting children five years old and below accounts for approximately 63% of the global diarrhoea burden ([@bib177]; [@bib197]), and is the second significant cause of infant mortality in developing nations ([@bib135]; [@bib94]) where poor sanitation and insufficient potable water supply are key factors ([@bib36]; [@bib154]). In Africa, Asia, and South America, diarrhoea accounts for one in eight deaths among children younger than 5 years per annum ([@bib89]; [@bib94]) and an estimated 16% of child deaths in Nigeria annually ([@bib38]). In Ogun State, South-West Nigeria, diarrhoea is one of the three diseases (the others being typhoid fever and cholera) which together are the second most prevalent water-related disease ([@bib125]).

Acute diarrhoea, the passage of stools with abnormal consistency and frequency in a day (e.g. more than three times) which lasts for less than two weeks, is a syndrome that is frequently not subject to differential diagnosis in medical practice ([@bib133]; [@bib197]). Bacterial diarrhoeal cases are the most prevalent of all diarrhoeal cases around the globe ([@bib196]). Commonly reported enteric bacterial diarrhoeal diseases and the causative agents are botulism (*Clostridium botulinum*), Campylobacter gastroenteritis (*Campylobacter jejuni)*, cholera (*Vibrio cholerae*), *Escherichia coli* gastroenteritis, Salmonellosis (various *Salmonella serovars*), Shigellosis (*Shigella spp*.), and Staphylococcal food poisoning (*Staphylococcus aureus* enterotoxins) ([@bib79]; [@bib159]). Children below five years of age have the most at risk from foodborne pathogens, including Shiga toxin-producing *Escherichia coli* O157, *Campylobacter*, *Shigella, Yersinia, Salmonella*, and *Cryptosporidium* ([@bib101], [@bib102]; [@bib94]). In the past few decades, the awareness in handwashing has tremendously reduced the burden of diarrhoea caused by enteric bacteria and protozoans, yet, it has less impact on diarrhoea caused by viruses ([@bib157]).

The mouth is the typical portal of entry for gastrointestinal pathogens, which are ingested alongside contaminated food and water ([@bib140]). Also, they are acquired via contact with diarrhoeic animals and their contaminated environments or with the faecal matter of a diarrhoeic person ([@bib79]; [@bib154]). While in their gastrointestinal habitat, these pathogens, through a variety of pathological mechanisms by which they could be typed, trigger the over secretion of fluid in the lumen of the small intestine associated with electrolyte imbalance, and eventual diarrhoea ([@bib79]; [@bib41]). In spite of the huge burden of diarrhoea, it is preventable with modern science and public health intervention ([@bib34], [@bib35]). In some cases, diarrhoea may be self-limiting. In severe infections, however, antibiotics may be prescribed to prevent possible death. The resulting risk, however, is antibiotic resistance, which is an important public health threat towards the treatment of diarrhoea ([@bib33]). The continuous surveillance of antimicrobial resistance is an epidemiological strategy at tracking new and emerging resistances to some of the last-line antibiotics.

Accurate diagnosis of diarrhoeal pathogens is necessary for surveillance, prevention, and control of diarrhoea ([@bib138]; [@bib159]). Traditional, phenotypic tests such as Gram staining, bacteriological culture and recording of colonial characteristics, and biochemical tests form the mainstay of laboratory diagnosis in less developed countries ([@bib101], [@bib102]). However, such tests take longer turnaround time to identify slow-growing bacteria, resulting in delayed treatment of patients ([@bib90]; [@bib109]). In many other cases, the results of these tests, even when considered in concert, are false negatives ([@bib113]).

Conventional epidemiological typing methods which include biotyping, antibiogram, and serotyping are quite useful in describing temporal epidemiological studies ([@bib108]). However, aetiological agents of approximately 40% of gastroenteritis cases go undetected by these methods, complicating diagnosis and treatment ([@bib60]; [@bib90]).

Molecular approaches have increasingly brought to light significant viral, parasitic, and bacterial enteric pathogens and also their virulent traits ([@bib199]). Most molecular techniques employ polymerase chain reaction (PCR) to detect deoxyribonucleic acid (DNA) in a sample ([@bib37]). One of the tools in molecular epidemiology is microbial typing. Microbial typing helps to diagnose the aetiology and the route of transmission of infection, identify virulent and resistant strains and evaluate the impact of control measures of infectious diseases ([@bib138]). Next-generation sequencing (NGS), a technique which quickly and extensively sequences a mixed population of DNA or ribonucleic acid (RNA) genomes have enhanced the study of infectious disease epidemiology ([@bib136]). Metagenomics, which is the technique that directly sequences and analyses the total nucleic acids isolated from a sample, without culture, has a promising prospect in the field of infectious disease diagnosis ([@bib45]).

Globally, researchers are already utilizing metagenomics in the aetiology and antimicrobial resistance surveillance of diarrhoea ([Table 1](#tbl1){ref-type="table"}). Conversely, most of the studies on diarrhoea aetiology in Sub-Saharan Africa has focused more on the prevalence, antimicrobial profile, and risk factors ([@bib70]; [@bib7]; [@bib39]). A few studies have reported the molecular characterisation of enteric pathogens isolated from diarrhoea patients ([@bib81]; [@bib164]). This review aims at highlighting recent trends in the epidemiology and treatment of enteric infections and gives an overview of the recent molecular methods of diagnosis. In furtherance, the potentials of metagenomics as a diagnostic method for diarrhoea infections will be highlighted.Table 1Application of metagenomics in diarrhoea diagnosis.Table 1CountryReferencesMetagenomic methodAge (year)Sample size (n)Type of organisms detectedAustralia[@bib60]Micro-mass sequencing0--512VirusesJapan[@bib118]454 Roche341BacteriaBangladesh[@bib150]454 RocheAll105VirusesGermany[@bib107]Deep Amplicon sequencingn/a45BacteriaBangladesh[@bib115]454 parallel sequencing2--39BacteriaAustralia[@bib75]454 Titanium platform0--58VirusesNicaragua[@bib17]16S rRNA amplicon sequencing0--566BacteriaCoted'Ivoire[@bib144]ShotgunAll4Multi-pathogensU.S. A[@bib192]16S rRNAAdults99Bacteria and virusesChina[@bib156]Deep amplicon sequencing0--57VirusesU.S. A[@bib199]Shotgun/WGS0--1822Multi-pathogensIsrael[@bib27]I6S rRNA amplicon sequencingAll196BacteriaDenmark[@bib84]Deep amplicon sequencing0--9558BacteriaBangladesh[@bib91]16S rRNA amplicon sequencing0--271BacteriaEthiopia[@bib4]RT-PCR/Illumina Miseq0--5269VirusesChina[@bib100]16S rDNA amplicon sequencing0--120BacteriaCameroun[@bib190]Deep amplicon sequencing0--89221Viruses

2. Epidemiology of diarrhoea {#sec2}
============================

2.1. Severity and trend of diarrhoea among children {#sec2.1}
---------------------------------------------------

The four major infectious diseases that cause death in children under the age of 5 are pneumonia, diarrhoeal diseases, malaria and measles ([Figure 1](#fig1){ref-type="fig"}). However, 25% and 31% of the overall diarrhoeal burden has been attributed to diarrhoea among children below the age of 5 in Africa and Asia respectively ([@bib177]), especially Sub-Saharan Africa which has the highest death rate ([Figure 2](#fig2){ref-type="fig"}). Despite the global decline in the diarrhoea mortality rate from 11% in 2010 to 9% in 2015, it is still the second cause of mortality among children under five years of age ([@bib105]; [@bib104], [@bib106]).Figure 1Causes of child deaths worldwide; Source: [@bib105].Figure 1Figure 2Data showing the high rate of diarrhoea morbidity among children below 5 years in Nigeria and some Asian Countries. Source: Computed by the Researcher with data from <https://data.unicef.org/topic/child-health/diarrhoeal-disease/>Accessed 17^th^ February 2019.Figure 2

2.2. Types of diarrhoea {#sec2.2}
-----------------------

i.Acute watery diarrhoea

Acute watery diarrhoea often presents with sudden development of an unusual frequent stooling of mostly fluid. Other signs are vomiting, fever, nausea and abdominal pain ([@bib48]). In the gastrointestinal tract, absorption of over 90% of the physiologic net fluid takes place in the proximal small intestine. The pathogenic mechanism that leads to diarrhoea occurs when enteric pathogens attack the proximal small intestine ([@bib162]). Acute watery diarrhoea is often caused by enterotoxin-secreting bacteria such as enterotoxigenic *Escherichia coli* (ETEC), and *Vibrio cholerae,* which cause fluid loss without cellular injury ([@bib184]). Viruses such as rotaviruses and calciviruses that damage the intestinal epithelium also cause fluid loss. Besides, they have more tendency to cause fever, vomiting and watery stools without blood and mucus ([@bib157]). Usually, cases of watery diarrhoea run an acute but brief (1--3 days) self-limiting duration.ii.Dysentery

As defined by World Health Organization, dysentery is bloody diarrhoea, i.e. any diarrhoeal episode in which the loose or watery stools contain visible red blood ([@bib172]) Dysentery is most often caused by *Shigella* species (bacillary dysentery) or *Entamoeba hystolytica* (amoebic dysentery). Dysentery starts with the sudden onset of repeated stooling. However, unlike acute watery diarrhoea, stools are often smaller in quantity and are characterized by blood and pus. Thus, it is also referred to as acute bloody diarrhoea. Dysentery usually presents with fever, tenesmus, abdominal pain, and cramps; vomiting occurs less often ([@bib179]). Inflammation of the colon (the part of the large intestine that extends from the cecum to the rectum) due to infection by one of a number of enteric pathogens leads to dysentery. The main cause of dysentery in children is the Shigellae ([@bib165]). *Campylobacter jejuni* and enteroinvasive *E. coli* or salmonellae of many serotypes being relatively less frequent causes. *Entamoeba histolytica* seldom causes dysentery in young children ([@bib90]: [@bib46]). Dysentery usually requires antimicrobial therapy ([@bib185]).iii.Persistent Diarrhoea

Persistent diarrhoea is acute as well as prolonged (at least 14 days) rather than brief also referred to as chronic diarrhoea ([@bib34], [@bib35]). The case may begin with the passage of frequent watery or bloody stool but last for a long period thus causing loss of weight. It accounts for less than ten percent of all diarrhoea but is responsible for 30 to 50 percent of death caused by diarrhoea ([@bib22]). Persistent diarrhoea has different causes which are either infectious or non-infectious. The infectious causes include intestinal parasites (Cryptosporidium, Cyclospora, *E. histolytica*, Giardia, Microsporidia), bacteria (*Aeromonas*, *Campylobacter*, *C*. *difficile*, *E*. *coli*, *Plesiomonas*, *Salmonella*, *Shigella*), and viruses (norovirus, rotavirus). While the non-infectious causes include altered immune function, disorders of the pancreas, medications (antibiotics), heritable metabolic disorders (enzyme deficiency), intolerance to some food products (gluten, lactose), intestinal disorders, disorders o the thyroid, and reduced blood flow to the intestines ([@bib34], [@bib35]; [@bib74]; [@bib153]; [@bib54]). Major organisms that are responsible for persistent diarrhoea are enteroaggregative *E. coli, Shigella*, and *Cryptosporidium* ([@bib50])*.* The pathogenesis of persistent diarrhoea could be multifactorial and fundamentally based on continuous damage to the mucosal linings o the intestines due to several infections with different pathogens ([@bib68]). Malnutrition also increases the likelihood of death in children with persistent diarrhoea. Evidence-based studies have established a strong relationship between chronic diarrhoea and HIV-positive patients in developing countries ([@bib2]; [@bib67]; [@bib95]; [@bib142]).

2.3. Aetiology of diarrhoeal diseases {#sec2.3}
-------------------------------------

The aetiology of diarrhoea may be infectious or non-infectious. In non-infectious diarrhoea cases, factors such as food intolerances (lactose and gluten), intestinal complications (irritable bowel syndrome, ulcerative colitis, Crohn\'s disease, and celiac disease), and reactions to drugs ([@bib79]).

Before the late 1960s, less than 20% of enteric infection symptoms could be linked to a specific aetiological agent by any known diagnostic method ([@bib3]). Diarrhoeal diseases are caused by several viral, bacterial, and protozoan species ([@bib135]; [@bib197]). Co-infections by a spectrum of enteric pathogens is the norm in diarrhoeal diseases ([@bib146]; [@bib16]). Rotaviruses and diarrhoeagenic *E. coli* (DEC) are the most reported enteropathogens globally, with the DEC being particularly important in resource low countries ([@bib126]).

Evidence based studies from Sudan ([@bib1]), Burkina Faso ([@bib25]; [@bib127]), China ([@bib197]), Nigeria ([@bib57]), and other endemic regions reveals that a significant amount of diarrhoea episodes in children are caused by enteric viruses. Rotaviruses, Noroviruses, Adenoviruses, Bocavirusese and Calciviruses have been implicated in childhood diarrhoea ([@bib9]). However, recent reports show rotaviruses as the major cause of fatal cases among children below 5 years old ([@bib65]; [@bib120]; [@bib69]). Moreover, group A rotavirus, in particular, is the prominent aetiological agent that is responsible for infantile gastroenteritis globally, causing an estimated 20% of diarrhoea-related deaths in children below the age of five. Low-income countries and those which have no running RVA vaccination programmes are particularly affected by the rotavirus group A (RVA) diarrhoea ([@bib65]; [@bib197]; [@bib41]).

Diarrhoeagenic *E. coli* (DEC) has been grouped into six pathotypes based on their pathogenic processes and clinical features. These subtypes are enteropathogenic *E. coli* (EPEC), enterohemorrhagic *E. coli* (EHEC), enterotoxigenic *E. coli* (ETEC), enteroinvasive *E. coli* (EIEC), enteroaggregative *E. coli* (EAEC), and diffusely adherent *E. coli* (DAEC). DEC pathotypes have also been further categorised based on their virulence mechanisms ([@bib195]; [@bib197]; [@bib161]). Also, there are important regional variations in the prevalence of the different DEC pathotypes. DEC pathotypes from different locations around the globe are genetically diverse ([@bib193]).

In outbreak situations, *Vibrio cholerae*, *Escherichia coli* and *Clostridium difficile* have been reported as the causative agents of diarrhoea in Bangkok ([@bib42]), China ([@bib143]; [@bib59]), Yemen ([@bib32]; [@bib181]), Iran ([@bib158]) and Nigeria ([@bib52]; [@bib97]; [@bib174]; [@bib55]). The role of viruses as agents of diarrhoea outbreaks among children cannot be overemphasized. Astroviruses in Bankok ([@bib149]), Noroviruses in China ([@bib141]), and Rotaviruses in India and Botswana ([@bib13]; [@bib58]) have been implicated in childhood diarrhoea outbreaks.

The parasitic diarrhoeal diseases of public health importance are Amebiasis (*Entamoeba histolytica*), Cryptosporidiosis (*Cryptosporidium spp*) and Giardiasis (*Giardia lamblia*). The two predominant causes that have been reported are *Cryptosporidium* and *Giardia*, of which *Cryptosporidium* is the more medically important across the world ([@bib93]; [@bib154]; [@bib169]). However, studies from China ([@bib194]), Ghana ([@bib119]), Nigeria ([@bib82]; [@bib7]), Kenya ([@bib112]) and [@bib30] have detected other enteric parasites such as *G. duodenalis*, *E. bieneusi, Schistosoma mansoni* and *C. cayetanensis* among diarrhoeic children, though at very low proportion when compared to bacteria and viruses.

2.4. Mode of transmission of diarrhoea {#sec2.4}
--------------------------------------

Diarrhoea-causing pathogens are usually spread via the faecal-oral route through the consumption of food or fluid infected with faecal matter, or direct contact with infected stools ([@bib134]; [@bib92]).

2.5. Risk factors for diarrhoea in children {#sec2.5}
-------------------------------------------

i.Duration of breastfeeding

Breastfeeding has a huge impact on the health status of children. A significant correlation exists between breastfeeding and diarrhoea episodes ([@bib70]; [@bib148]). Sub-optimal breastfeeding increases the risk of developing diarrhoea because breast milk can confer proper functioning of the gut immune system in infants, both for a short- and long-term duration ([@bib15]; [@bib122]). Also, breast milk decreases a newborn\'s risk of contracting gut diseases because it is made up of antibodies, immunoglobulin A (IgA), which confer protection against pathogenic bacteria and harmonize the activity of white blood cells ([@bib184]; [@bib73]).

In Africa, the rate of breastfeeding in Nigeria is lower than that in Uganda, Ethiopia, and Tanzania ([@bib121]). This would mean that there might be a higher risk of infants presenting with diarrhoea in Nigeria than in the other countries of comparison ([Figure 2](#fig2){ref-type="fig"}). Infants should be given breast milk within the first hour after birth and breastfeeding should be exclusively practised during the first six months before feeding with supplementary foods ([@bib188]). The initiation of supplementary food before the end of the first six months increases the risk of contamination, especially in the less developed countries where potable water and basic sanitation is lacking ([@bib47]).ii.The Source of drinking water

Consumption of contaminated water is a viable means of transmission of diarrhoea-causing pathogens. Contamination may occur at the water source, during storage by unhygienic packaging, or during mealtimes through contact with unwashed hands or exposure ([@bib134]; [@bib180]). The availability of potable water may not necessarily be taken for granted in every part of the world; but the challenge of insufficient or outright lack of potable water is worse in less developed countries, thus predisposing their populations to a higher burden of diarrhoeal diseases ([@bib125]). Unhygienic handling of drinking water is also an attributable factor for diarrhoea in children ([@bib124]; [@bib36]).iii.Hygiene and Sanitation

Non-adherence of mothers/caregivers to the practice of handwashing predisposes their children/wards to diarrhoea ([@bib36]). Infant feeding bottles, which can be easily contaminated with faecal bacteria may, in turn, contaminate milk held in them, and milk encourages bacteria growth if not consumed immediately ([@bib124]; [@bib86]; [@bib180]). Also, unhygienic sewage disposal and the use of crude toilet facilities may predispose children to diarrhoea ([@bib88]).iv.Age

Globally, the prevalence of diarrhoea has been reported to be higher in children than in adults, especially among children below five years ([@bib178]; [@bib38]; [@bib197]). Diarrhoea incidence among children has been reported to be highest in the age group below 24 months and declines with an increase in age ([@bib177]; [@bib8]).v.The Level of Maternal Educational

The impact of the educational level of mothers in the health status of their children is important because it is directly related to their awareness levels. Mothers without formal education are more likely to have children who will suffer diarrhoeal diseases when compared to educated mothers ([@bib47]). Moreover, because access to formal education is limited in rural areas where more males than females go to school, there is a higher rate of uneducated mothers in such locations thus increasing the risk of children having diarrhoea in rural environments ([@bib85]).

Apart from the factors listed above, vitamin A deficiency ([@bib53]; [@bib155]), zinc deficiency ([@bib178]; [@bib167]), childhood wasting ([@bib114]; [@bib168]), low use of ORS ([@bib38]), mother\'s handwashing ([@bib200]; [@bib201]), childhood stunting ([@bib96]) and low rotavirus vaccine coverage ([@bib167]) have been indicated as risk for childhood diarrhoea in developing countries.

3. Approaches to diarrhoeal diseases diagnosis {#sec3}
==============================================

The polymicrobial nature of diarrhoea aetiology requires the medical microbiologist to harness the differential diagnosis towards establishing the causative agent of the disease ([@bib130]; [@bib79]). Accurate detection of the etiologic agent is a very important step for diarrhoeal disease surveillance and control activities ([@bib159]).

3.1. Conventional diagnostics {#sec3.1}
-----------------------------

The traditional approach to the diagnosis of infectious diarrhoea includes Gram staining and microscopic examination, plate culture (and records of morphological characteristics), toxin assay, antigen-antibody assay, and biochemical testing ([@bib3]). They are still being routinely used in clinical laboratories to detect and identify enteric pathogens ([@bib103]). They have good sensitivity and specificity ([@bib136]), but are quite laborious ([@bib107]), because they must include a battery of methods to detect a spectrum of potential viruses, bacteria, and parasites ([@bib37]). Also, time of identification takes longer, a factor which may threaten the chance of proper antibiotic and supportive therapy and ultimately of survival for a patient in a critical condition.

Laboratory diagnosis that is culture-based often produce low yield for enteropathogens and this may hamper antibiotic therapy ([@bib61]). Although stool microscopy for parasite detection is broadly used, it is, however, insensitive, time-consuming, and requires equipment and training ([@bib130]; [@bib50]). Moreover, bacteria referred to as 'viable but not culturable' (VBNC), as well as, 'difficult to culture' (DTC), are often missed out of the identification process. It has been estimated that only about 1% of bacteria are culturable ([@bib10]).

3.2. Molecular diagnosis of diarrhoeal diseases {#sec3.2}
-----------------------------------------------

Molecular diagnostics, which generally utilise the amplification of DNA or RNA, are increasingly relevant in infectious disease diagnosis. Molecular epidemiology uses the genetic sequence of microorganisms and their hosts to describe the disease patterns as well as gain insight into possible gene function and origin by describing the distribution of genes or gene according to person, place, and time characteristics. Microbial DNA can be detected in all types of samples. The two approaches to molecular detection of microbes are the culture-based and culture-independent methods.

Culture-dependent molecular methods require that microbes are grown in culture media in the laboratory under optimum growth requirements before DNA is extracted for further molecular processing. On the other hand, culture-independent molecular methods do not require microbes to be cultivated on culture plates for DNA isolation. Rather, DNA is extracted directly from samples ([@bib71]; [@bib107]).

3.3. Polymerase chain reaction {#sec3.3}
------------------------------

Polymerase chain reaction (PCR) is by far the most widely used method for nucleic acid amplification. Among several biomarkers for pathogen detection, nucleic acids are the ultimate. Molecular targets for many enteropathogens are known. Some researchers have utilised multiplex PCR ([@bib103]; [@bib126]), array singleplex PCR ([@bib101], [@bib102]; [@bib136]), and quantitative PCR ([@bib50]) in diarrhoeal research.

3.4. Metagenomics {#sec3.4}
-----------------

Metagenomics, which is the culture-independent genomic analysis of microbial communities, has emerged as an influential new research tool in microbiology over the last twenty years ([@bib10]). There are basically two approaches, the deep amplicon sequencing (DAS) or metagenome shotgun sequencing (MSS) ([@bib113]). In diarrhoea diagnosis, the Bacterial DAS strategy typically entails the use of universal primers such as 16S rRNA ([@bib113]; [@bib45]). On the other hand, shotgun sequencing utilizes the process of randomly breaking up DNA sequences into many small pieces and then rearranging them by targeting regions of overlap, thus generating sequencing data that are naturally immune to primer bias ([@bib72]). The shotgun approach has a wider coverage in terms of application in microbial community studies.

Other molecular biology techniques deal with the extraction of genomic DNA from an individual organism or cell from a pure isolate, whereas, metagenomics focuses on the direct investigation of total genomic DNA from clinical specimens. Rich phylogenetic information can be harnessed from amplicons of either or both of the two variant regions V3 and/or V6 of 16S ribosomal DNA (rDNA) of the bacteria in samples when pyro-sequenced ([@bib113]).

Unlike the DAS, shotgun metagenomic sequencing approach can potentially detect all of the microbes present in a sample, despite their kingdom of origin, by sequencing all the nucleic acids extracted from a specimen ([@bib199]). Therefore, its application in the analysis of the diversity and the metabolic potential of microbial communities is indispensable, especially as only a few microorganisms in nature are culturable ([@bib128]; [@bib107]). Shotgun metagenomics has the potential to detect completely novel genes ([@bib63]). Apart from the detection of enteric pathogens, shotgun metagenomics has other applications in diarrhoea epidemiology. It can be used to investigate the phylogenetic diversity of microbial genes or gene products, antimicrobial resistance genes, and virulence genes ([@bib77]; [@bib10]; [@bib199]; [@bib27]).

Recent reports from around the world suggest the potential of metagenomics as a useful tool in diarrhoea diagnosis ([@bib17]; [@bib156]; [@bib91]; [@bib4]). [@bib18], predict a rising frequency in the application of metagenomic techniques in paediatric medicine. Enteric pathogens, including viruses, bacteria, and protozoans have been identified using different metagenomics methods such as micro-mass sequencing, pyro-sequencing, amplicon sequencing, shotgun sequencing, and whole-genome sequencing ([Table 1](#tbl1){ref-type="table"}). Despite the many advantages of metagenomics in pathogen detection, the major drawback is the enormous data that are often generated which require in-depth bioinformatics software application.

3.5. Bioinformatics {#sec3.5}
-------------------

A very crucial part of metagenomics technique is the application of bioinformatics tools, especially for data analysis. The application of gene sequencing in epidemiology brings about huge data ([@bib128]). Bioinformatics is the discipline that focuses on the development of ways to use computer software\'s to characterise molecular components of living things. In the past few decades, molecular epidemiology focused on strain typing for outbreak and surveillance investigation. The ability to analyse genetic sequences from microbes has transformed the molecular epidemiology of infectious diseases. Therefore, modern molecular epidemiology relies on new phylogenetic methods that enable the analysis of genetic data to estimate epidemiologic parameters and link epidemic processes to pathogen evolution ([@bib62]; [@bib71]).

Recent studies reveal the significance of bioinformatics tools in the diagnosis of clinically challenging cases such as asymptomatic clinical presentations ([@bib23]; [@bib131]). Besides, there are pieces of evidence showing that bioinformatics is a very reliable epidemiological tool during disease and antimicrobial resistance surveillance ([@bib20]; [@bib64]; [@bib87]; [@bib191]). Also, with bioinformatics applications, scientists are already discovering new drug targets for the treatment of diarrhoeal diseases ([@bib10]; [@bib171]).

4. Treatment and management of diarrhoeal diseases {#sec4}
==================================================

The common treatment options for diarrhoeal diseases are fluid replacement and antimicrobial therapy. Fluid replacement therapy also referred to as oral rehydration therapy (ORT) is especially necessary for young children ([@bib80]; [@bib29]). In Nigeria, cereal-based oral therapies and home-made fluids have proven to be effective in diarrhoea management ([@bib132]).

In some instances, diarrhoea cases may be self-limiting. However, during severe cases of infection (persistent diarrhoea or dysentery), antimicrobial agents are required ([@bib28]). The first line antimicrobial agents for childhood diarrhoea therapy are co-trimoxazole and metronidazole which could be administered empirically. Others include penicillin, erythromycin, amoxycillin, ampicillin, cefuroxime, ceftriaxone, tetracycline, chloramphenicol, and ampicillin/cloxacillin, azithromycin, ciprofloxacin, and rifaximin ([@bib170]; [@bib29]). [@bib76], reported co-trimoxazole, norfloxacin, colistin sulfate, and nalidixic acid as the frequently recommended antibiotics for childhood therapy in Thailand. A study in Nigeria showed that metronidazole is the most prescribed antibiotic, followed by co-trimoxazole and gentamycin ([@bib170]). Parenteral treatment with ceftriaxone or ciprofloxacinis recommended for severe diarrhoea cases ([@bib29]). Childhood diarrhoea caused by *Shigella* is responsible for most cases of mortality in non-bloody diarrhoea ([@bib104], [@bib106]) and morbidity in moderate diarrhoea ([@bib11]), among children under five years in developing countries.

However, the emergence/re-emergence of antibiotic-resistant strains of enteric pathogens is becoming a huge threat ([@bib184]). Worldwide, there are reports on multidrug-resistant strains of enteropathogens isolated from stools of children under five years ([@bib56]). For instance, multidrug resistant Shigella spp has been reported in Ethiopia ([@bib66]), Mozambique ([@bib176]), and Nigeria ([@bib6]).

Other treatment options include immunotherapy which is an alternative treatment option ([@bib163]; [@bib117]; [@bib198]), fortified nutrition such as iron fortification and zinc replacement therapy ([@bib129]; [@bib175]; [@bib183]), lactose-free diet ([@bib80]), probiotics, though is limited awareness in Nigeria ([@bib5]; [@bib114]; [@bib51]), and faecal microbiota transplantation which has been used mostly in *Clostridium difficile*-associated diarrhoea ([@bib12]; [@bib40]; [@bib14]). Oral zinc therapy could help reduce the severity and duration of diarrhoea in children above six months but may not have significant effect in children under six months of age ([@bib98]). Besides, Zinc absorption during diarrhoea may be reduced and vomiting may be a possible side effect ([@bib123]; [@bib152]). In Bangladesh, a combination of ORS, zinc and vitamin A supplementation was very effective at reducing death in children caused by diarrhoea ([@bib21]).

4.1. Prevention and management of diarrhoeal infections {#sec4.1}
-------------------------------------------------------

An adequate supply of potable water, sanitation, and vaccination are the main means of preventing diarrhoeal infections ([@bib47]).a)Improved Water Supply and Sanitation

Acute diarrhoeal diseases can be prevented with a variety of measures focused on limiting the spread of organisms within the community and from person to person. Diarrhoeal diseases spread by the faecal-oral route. Therefore, handwashing is considered a key barrier to the transmission of enteric pathogens ([@bib186]). Studies from the developing world and from the U.S. and Australia childcare settings estimated 42%--47% reduction in the risk of diarrhoeal diseases by handwashing with soap ([@bib19]). Therefore, effective handwashing with soap should be practised by parents and caregivers before food preparation, before feeding their children and after leaving the toilet ([@bib124]; [@bib34], [@bib35]).

Globally, over 1 billion people lack access to improved drinking water supplies ([@bib184]) and over 2.4 billion live without adequate sanitation ([@bib43]). Strategies to improve the microbial quality of drinking water can be applied at the source or in the household. Water source strategy includes protected wells, boreholes and public tap stands ([@bib36]). Household strategies include improved water storage or approaches for treating water, such as chlorination, solar disinfection, filtration, or combined flocculation and disinfection ([@bib43]).b)Vaccines

Immunization has reduced the burden of diarrhoea in children. However, there are limited vaccines which protect against few and specific pathogens. There are two enteric infectious agents for which vaccines have been licenced for use at the present time, they include rotavirus and *V. cholerae* O1(([@bib137]).

4.2. *Rotavirus vaccine* {#sec4.2}
------------------------

Rotavirus vaccination has been very effective in reducing the hospitalization and death rate caused by diarrhoea in Africa. Studies by [@bib44], showed commendable reduction in rates of death (74%) and hospitalization (47--57%) caused by rotavirus in childhood diarrhoea. There are two types: a pentavalent rotavirus vaccine recommended for routine use in infants with three doses given at two, three, and six months respectively; and a monovalent rotavirus vaccine recommended as an alternative of two doses given at two and four months ([@bib147]; [@bib182]; [@bib116]). Rotarix and RotaTeq manufactured in Belgium and New Jersey respectively have been effective in the prevention of diarrhoea ([@bib114]; [@bib151]). Rotavac and BRV- PV produced in India have also proved to be promising. BRV-PV, is a heat-stable, live, oral bovine rotavirus pentavalent vaccine (given at 6, 10, and 14 weeks), which has undergone trial in Niger with a 66.7% efficacy against infantile diarrhoea caused by rotavirus ([@bib83]; [@bib145]).

4.3. The cholera vaccine {#sec4.3}
------------------------

The two oral cholera vaccines that are available for use and prequalified by the WHO are the oral, whole-cell, killed *V. cholerae* O1 vaccine supplemented with the B subunit of cholera toxin and the O139 vaccine without supplemented B with names as Dukoral, Shanchol, Euvichol, and mORC-Vax ([@bib139]; [@bib24]). These vaccines are given in two or three doses depending on age and produce protective efficacy against the moderate and severe disease of between 60% -85%, for up to two to three years after vaccination. They are less effective in children below two years and produce a shorter duration of protection in these individuals ([@bib99]). A field trial of the oral cholera vaccine was done in Mozambique, where two doses of Dukoral showed 78% protective efficacy against disease in a cholera outbreak.

4.4. New enteric vaccines {#sec4.4}
-------------------------

Recent trends show evidence of novel enteric vaccines. These include ETEC, Shigella, and norovirus vaccines. In the past two decades, research has been ongoing in the area of vaccine development using several methods which include live attenuated, killed whole-cell, and subunit techniques. Some of the new vaccines are in the preclinical and clinical stage of development ([@bib26]; [@bib111]; [@bib160]; [@bib114]).

5. Conclusion {#sec5}
=============

Diarrhoeal diseases remain an existential threat to global public health, especially to the children of ages five and below in low- and middle-income nations of the world, where access and the cost of quality healthcare remain below par and beyond affordable respectively. Treatment of childhood diarrhoeal diseases should be done within shorter turnaround times than ever before, given the need to reduce mortality due to them, especially during epidemic outbreaks. Conventional culture techniques, time-tested as they are, remain limited in offering rapid diagnosis, especially as a fair proportion of diarrhoeal pathogens are difficult-to-culture and yet-to-be-identified. Metagenomics and bioinformatics, in particular, offer great potentials in achieving a rapid diagnosis and epidemiological surveillance of diarrhoeal diseases, which in turn will lead to the outcome of rapid management, treatment, prevention, and control of diarrhoeal diseases.
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